Williams Integrated Technologies

Raising $1M for wireless cancer antigen monitor

Facebook Twitter LinkedIn

 
WIT has designed an electronic wireless device that will monitor the bloodstream for a recurrence of the defective proteins that mark particular malignancies as they grow. 
 
The I3C is a patented non-invasive method designed to monitor the blood antigen levels of cancer patients via protein antigen 
markers in the blood. This process can monitor Alzheimer’s and 8 other cancer antigens: colorectal, 
ovarian, uterus, cervix, esophageal, fallopian, gastrointestinal, certain variations of breast and lung, and prostate. 

Ready to Ask For Funding for your company?

Post a Funding Request